# Beta Bionics, Inc.: insider transactions

BBNX · Nasdaq · CIK 1674632 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbnx.md) · [Financials](/companies/bbnx/financials.md) · [Filings](/companies/bbnx/filings.md) · [Insiders](/companies/bbnx/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-27 | [Mensinger Mike](/insiders/2048500.md) | Chief Product Officer, Officer | Sale (S) | 2,650 | $22.00 | $58.3k | [Form 4](/filings/0002048500-26-000015.md) |
| 2026-10-26 | [Hopman Mark](/insiders/2048497.md) | Chief Commercial Officer, Officer | Sale (S) | 821 | $20.00 | $16.4k | [Form 4](/filings/0002048497-26-000023.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 16:23 ET. No prices; not investment advice.